(Q73764043)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

editorial

0 references

title

Percent free prostate-specific antigen for first-time prostate biopsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

C T Lee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P T Scardino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

594-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Longitudinal screening for prostate cancer with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2900912-8

7 January 2021

10.1016/S0090-4295(01)00912-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306355%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference